Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
Faculty of Medicine, University of Oslo, Oslo, Norway.
Acta Ophthalmol. 2023 Feb;101(1):100-108. doi: 10.1111/aos.15207. Epub 2022 Jun 25.
BACKGROUND/AIMS: To compare outcomes of acute endophthalmitis (EO) managed with either primary vitrectomy (PV) or primary intravitreal antibiotics (vancomycin and ceftazidime) followed by early vitrectomy (PIAEV) combined with polymerase chain reaction (PCR)-based diagnostics.
This was a prospective, comparative observational study of acute EO cases admitted to a regional vitreoretinal service over 18 months. Depending on whether immediate vitrectomy (within 6 h) was achievable, the EO cases were treated with either (1) PV or (2) PIAEV. Microbiology samples were collected either (A) before or (B) after administration of intravitreal antibiotics. The samples were analysed with broad-range 16S PCR and culture.
The study included 41 EO cases. There were 19 post-injection EO, 18 post-cataract EO, three post-vitrectomy EO, and one blebitis-related EO. Fifteen of 19 PV cases and 15 of 21 PIAEV had a clinically meaningful improvement in best-corrected visual acuity (BCVA) of at least 15 letters at 3 months (p = 0.58). One patient was lost to follow-up. Twenty-three cases were culture- and PCR-positive, and seven additional cases were culture-negative but PCR-positive (p = 0.02). PCR increased the diagnostic yield for samples collected both before and after administration of intravitreal antibiotics.
Primary vitrectomy or PIAEV allowed for vitrectomy for all cases of acute EO in a large region. Most eyes in both groups achieved a clinically meaningful improvement in BCVA. By combining culture with PCR in connection with the vitrectomy procedure, intravitreal antibiotics could be injected before microbiological sampling, thereby improving the door-to-treatment time without sacrificing microbial identification.
背景/目的:比较采用玻璃体切除术(PV)或玻璃体腔内抗生素(万古霉素和头孢他啶)联合早期玻璃体切除术(PIAEV)联合聚合酶链反应(PCR)检测治疗急性眼内炎(EO)的效果。
这是一项前瞻性、比较性的观察性研究,纳入了在 18 个月内入住区域性玻璃体视网膜服务的急性 EO 病例。根据是否可以立即进行玻璃体切除术(6 小时内),EO 病例分别接受(1)PV 或(2)PIAEV 治疗。微生物样本分别(A)在玻璃体腔内抗生素给药前或(B)给药后采集。对样本进行广谱 16S PCR 和培养分析。
研究纳入了 41 例 EO 病例。其中 19 例为注射后 EO,18 例为白内障手术后 EO,3 例为玻璃体切除术后 EO,1 例为眼内炎相关 EO。19 例 PV 病例中有 15 例和 21 例 PIAEV 病例在 3 个月时最佳矫正视力(BCVA)至少提高 15 个字母时有临床意义的改善(p=0.58)。1 例患者失访。23 例培养和 PCR 阳性,7 例培养阴性但 PCR 阳性(p=0.02)。PCR 提高了玻璃体腔内抗生素给药前后采集样本的诊断率。
在一个大区域,急性 EO 的所有病例都可以进行玻璃体切除术或 PIAEV。两组大多数眼的 BCVA 均有临床意义的改善。通过在玻璃体切除术过程中结合培养和 PCR,在进行微生物取样前可以注射玻璃体腔内抗生素,从而在不牺牲微生物鉴定的情况下缩短治疗时间。